The target landscape of clinical kinase drugs

Journal: Science

Published: 2017-12-01

DOI: 10.1126/science.aan4368

Affiliations: 20

Authors: 48

Go to article
Institutions FC
TUM Chair of Proteomics and Bioanalytics, Germany 0.30
German Consortium of Translational Cancer Research (DKTK), Germany 0.13
German Cancer Research Center in the Helmholtz Association (DKFZ), Germany 0.12
SAP Innovation Center, Germany 0.10
Nerviano Medical Sciences S.r.l., Italy 0.08
Research Unit Analytical Pathology (AAP), HMGU, Germany 0.04
Department of Internal Medicine III, LMU, Germany 0.03
TUM Institut für Klinische Chemie und Pathobiochemie, Germany 0.03
TUM Department of Internal Medicine III (Hematooncology/Oncology), Germany 0.02
University Medical Center Freiburg, Germany 0.02
SAP AG, Germany 0.02
Tartu University Hospital, UT, Estonia 0.02
Estonian Genome Center, UT, Estonia 0.02
Cluster of Excellence - Munich Center for Integrated Protein Science Munich (CiPS-M), LMU, Germany 0.01
Charité Institute of Physiology, Germany 0.01
Helmholtz Zentrum München - German Research Center for Environmental Health (HMGU), Germany 0.01
TUM Department of Chemistry, Germany 0.01
Helios Klinikum Krefeld, Germany 0.01
Department of Pediatrics, LMU, Germany 0.01
TUM Bavarian Center for Biomolecular Mass Spectrometry (BayBioMS), Germany 0